Lv1
18 积分 2021-11-11 加入
Pre‐Transplant MRD Negativity and Age Under 40 Predict Superior Long‐Term Survival in Relapsed/Refractory B‐ALL After CAR‐T Therapy Bridging to Haploidentical HSCT: A Multicenter Retrospective Study With 6‐Year Follow‐Up
2天前
已完结
Survival benefit of allogeneic HSCT in CMML patients during the molecular stratification era
3天前
求助中
Chronic active Epstein-Barr virus disease: molecular pathogenesis, evolving concepts, and emerging therapies
27天前
已完结
Haploidentical Hematopoietic Cell Transplantation Combined with Umbilical Cord Blood Versus Haploidentical Hematopoietic Cell Transplantation in T-Cell Acute Lymphoblastic Leukemia Patients: A Multicenter Real-World Study
1个月前
已完结
Ph-Positive Acute Lymphoblastic Leukemia — 25 Years of Progress
2个月前
已完结
The impact of TP53 mutations and TP53 deletions on survival varies between AML, ALL, MDS and CLL: an analysis of 3307 cases
2个月前
已完结
A clinical guide to TP53 mutations in myeloid neoplasms
2个月前
已完结
Putting function back in dysfunction: Endothelial diseases and current therapies in hematopoietic stem cell transplantation and cellular therapies
3个月前
已完结
GFI1 as a novel prognostic and therapeutic factor for AML/MDS
4个月前
已完结
First report of donor-derived active multiple myeloma from one AML patient after allogeneic stem cell transplantation
4个月前
已完结
皖公网安备34019202002308
